Deal-Making

Mesa Labs picks up Gyros in $180m bio QC deal
Deal-Making
Mesa Labs picks up Gyros in $180m bio QC dealMesa Labs picks up Gyros in $180m bio QC deal

Gyros Protein Technologies has been acquired by Mesa Laboratories in a deal worth $180 million

byBPI Staff
Nov 11, 2019
|
1 Min Read
Aspen alert! Novartis buys assets for $330m in Japan boost
Global Markets
Aspen alert! Novartis buys assets for $330m in Japan boostAspen alert! Novartis buys assets for $330m in Japan boost
byBPI Staff
Nov 11, 2019
1 Min Read
Cognate buys Cobra to boost gene therapy CDMO capabilities
Deal-Making
Cognate buys Cobra to boost gene therapy CDMO capabilitiesCognate buys Cobra to boost gene therapy CDMO capabilities
byBPI Staff
Nov 6, 2019
1 Min Read
LBPs for gene therapies: Thermo Fisher inks deal with another Bamforth biz
Deal-Making
LBPs for gene therapies: Thermo Fisher inks deal with another Bamforth bizLBPs for gene therapies: Thermo Fisher inks deal with another Bamforth biz
byDan Stanton
Nov 6, 2019
1 Min Read
Amgen takes $2.7bn stake in BeiGene to up presence in China
Global Markets
Amgen takes $2.7bn stake in BeiGene to up presence in ChinaAmgen takes $2.7bn stake in BeiGene to up presence in China
byDan Stanton
Nov 1, 2019
1 Min Read
Avacta teams with ADC Therapeutics on Affimer conjugates
Therapeutic Class
Avacta teams with ADC Therapeutics on Affimer conjugatesAvacta teams with ADC Therapeutics on Affimer conjugates
byGareth Macdonald
Nov 1, 2019
1 Min Read
Cesca and HealthBanks jump on the CAR-TXpress in cell banking JV
Deal-Making
Cesca and HealthBanks jump on the CAR-TXpress in cell banking JV
Cesca and HealthBanks jump on the CAR-TXpress in cell banking JV
Oct 30, 2019
|
1 Min Read
byGareth Macdonald
Chinese CMC: CMAB to make bi-functional antibody for BJ
Deal-Making
Chinese CMC: CMAB to make bi-functional antibody for BJ
Chinese CMC: CMAB to make bi-functional antibody for BJ
Oct 22, 2019
|
1 Min Read
byGareth Macdonald
Danaher offloads assets to Sartorius for $750m; GE buy pushed back to 2020
Upstream & Downstream Processing
Danaher offloads assets to Sartorius for $750m; GE buy pushed back to 2020
Danaher offloads assets to Sartorius for $750m; GE buy pushed back to 2020
Oct 21, 2019
|
1 Min Read
byDan Stanton, Editorial director
Combigene teams with Cobra and NBR on epilepsy gene therapy
Deal-Making
Combigene teams with Cobra and NBR on epilepsy gene therapy
Combigene teams with Cobra and NBR on epilepsy gene therapy
Oct 18, 2019
|
1 Min Read
byDan Stanton, Editorial director
Big M&A: Alexion in $930m Achillion buy, UCB bids $2.1bn for Ra
Deal-Making
Big M&A: Alexion in $930m Achillion buy, UCB bids $2.1bn for Ra
Big M&A: Alexion in $930m Achillion buy, UCB bids $2.1bn for Ra
Oct 16, 2019
|
1 Min Read
byBPI Staff
CDMO focus: Strategic gene therapy deals and $250m sell-off
Deal-Making
CDMO focus: Strategic gene therapy deals and $250m sell-off
CDMO focus: Strategic gene therapy deals and $250m sell-off
Oct 9, 2019
|
1 Min Read
byBPI Staff
Cellectis selects Lonza for off-the-shelf CAR-T manufacture
Deal-Making
Cellectis selects Lonza for off-the-shelf CAR-T manufacture
Cellectis selects Lonza for off-the-shelf CAR-T manufacture
Oct 4, 2019
|
1 Min Read
byBPI Staff
BWB startup pitch: Biopharm America's got talent
Deal-Making
BWB startup pitch: Biopharm America's got talent
BWB startup pitch: Biopharm America's got talent
Sep 17, 2019
|
1 Min Read
byDan Stanton, BPI Staff
Lundbeck adding migraine ‘blockbuster’ and Ab capabilities in $2bn Alder buy
Deal-Making
Lundbeck adding migraine ‘blockbuster’ and Ab capabilities in $2bn Alder buy
Lundbeck adding migraine ‘blockbuster’ and Ab capabilities in $2bn Alder buy
Sep 17, 2019
|
1 Min Read
byDan Stanton, Editorial director
Lonza to make ‘NET’ antibody for Citryll
Deal-Making
Lonza to make ‘NET’ antibody for Citryll
Lonza to make ‘NET’ antibody for Citryll
Sep 13, 2019
|
1 Min Read
byBPI Staff
MilliporeSigma buys data platform to bolster its Biopharma 4.0 offering
Upstream & Downstream Processing
MilliporeSigma buys data platform to bolster its Biopharma 4.0 offering
MilliporeSigma buys data platform to bolster its Biopharma 4.0 offering
Sep 6, 2019
|
1 Min Read
byDan Stanton, Editorial director
Vertex looks to stem cell islets for diabetes in $950m ‘toolbox’ deal
Deal-Making
Vertex looks to stem cell islets for diabetes in $950m ‘toolbox’ deal
Vertex looks to stem cell islets for diabetes in $950m ‘toolbox’ deal
Sep 4, 2019
|
1 Min Read
byDan Stanton, Editorial director
Batavia selects CHO platform for Zika Ab on the Horizon
Deal-Making
Batavia selects CHO platform for Zika Ab on the Horizon
Batavia selects CHO platform for Zika Ab on the Horizon
Sep 4, 2019
|
1 Min Read
byBPI Staff
Novartis to take on Biogen with Tysabri biosimilar pact
Global Markets
Novartis to take on Biogen with Tysabri biosimilar pact
Novartis to take on Biogen with Tysabri biosimilar pact
Sep 3, 2019
|
1 Min Read
byDan Stanton, Editorial director
Not all about that base: Catalent organic downside offset by M&A
Deal-Making
Not all about that base: Catalent organic downside offset by M&A
Not all about that base: Catalent organic downside offset by M&A
Sep 2, 2019
|
1 Min Read
byDan Stanton, Editorial director
Dyadic: Deals stack up as industry looks to ‘game-changing’ expression system
Deal-Making
Dyadic: Deals stack up as industry looks to ‘game-changing’ expression system
Dyadic: Deals stack up as industry looks to ‘game-changing’ expression system
Aug 16, 2019
|
1 Min Read
byDan Stanton, Editorial director
CMOs to continue picking up Big Pharma non-core facilities
Facilities & Capacity
CMOs to continue picking up Big Pharma non-core facilities
CMOs to continue picking up Big Pharma non-core facilities
Aug 14, 2019
|
1 Min Read
byDan Stanton, Editorial director
AskBio buys Synpromics, plans expansion
Deal-Making
AskBio buys Synpromics, plans expansion
AskBio buys Synpromics, plans expansion
Aug 13, 2019
|
1 Min Read
byBPI Staff
Lonza to simplify vein-to-vein supply chain with Vineti partnership
Therapeutic Class
Lonza to simplify vein-to-vein supply chain with Vineti partnership
Lonza to simplify vein-to-vein supply chain with Vineti partnership
Aug 13, 2019
|
1 Min Read
byDan Stanton, Editorial director
Pfizer licenses AAV platform for ataxia gene therapy
Deal-Making
Pfizer licenses AAV platform for ataxia gene therapy
Pfizer licenses AAV platform for ataxia gene therapy
Aug 9, 2019
|
1 Min Read
byBPI Staff
Novo Nordisk to convert Purdue NC plant to make oral diabetes drug
Facilities & Capacity
Novo Nordisk to convert Purdue NC plant to make oral diabetes drug
Novo Nordisk to convert Purdue NC plant to make oral diabetes drug
Aug 5, 2019
|
1 Min Read
byDan Stanton, Editorial director
Challenging the vaccine space: The problem with pioneers
Global Markets
Challenging the vaccine space: The problem with pioneers
Challenging the vaccine space: The problem with pioneers
Aug 1, 2019
|
1 Min Read
byBPI Staff
Danaher: ‘All indications show GE is in wonderful shape’
Upstream & Downstream Processing
Danaher: ‘All indications show GE is in wonderful shape’
Danaher: ‘All indications show GE is in wonderful shape’
Jul 31, 2019
|
1 Min Read
byDan Stanton, Editorial director
Big Pharma M&A a boon for business, says Thermo Fisher
Global Markets
Big Pharma M&A a boon for business, says Thermo Fisher
Big Pharma M&A a boon for business, says Thermo Fisher
Jul 30, 2019
|
1 Min Read
byDan Stanton, Editorial director
VGXI to supply plasmid for Geneos’ cancer DNA vaccines
Deal-Making
VGXI to supply plasmid for Geneos’ cancer DNA vaccines
VGXI to supply plasmid for Geneos’ cancer DNA vaccines
Jul 23, 2019
|
1 Min Read
byDan Stanton, Editorial director
Pall to provide ‘A-Z of single-use tech’ in Servier deal
Upstream & Downstream Processing
Pall to provide ‘A-Z of single-use tech’ in Servier deal
Pall to provide ‘A-Z of single-use tech’ in Servier deal
Jul 19, 2019
|
1 Min Read
byDan Stanton, Editorial director
Boehringer to buy cancer vaccine firm AMAL for €325m
Deal-Making
Boehringer to buy cancer vaccine firm AMAL for €325m
Boehringer to buy cancer vaccine firm AMAL for €325m
Jul 16, 2019
|
1 Min Read
byBPI Staff
Rights of Passage: Paragon building dedicated gene therapy suite
Facilities & Capacity
Rights of Passage: Paragon building dedicated gene therapy suite
Rights of Passage: Paragon building dedicated gene therapy suite
Jul 12, 2019
|
1 Min Read
byDan Stanton, Editorial director
Instrumental deal: Agilent to bolster cell analysis biz with BioTek buy
Deal-Making
Instrumental deal: Agilent to bolster cell analysis biz with BioTek buy
Instrumental deal: Agilent to bolster cell analysis biz with BioTek buy
Jul 12, 2019
|
1 Min Read
byDan Stanton, Editorial director

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Ask the Expert webcasts
ATE Webcasts
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Ask the Expert webcasts
ATE Webcasts
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Thermo Fisher White Paper
Sponsored Content
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies

Nov 21, 2024

Thermo Fisher WP
Sponsored Content
Efficient-Pro Medium and Feed 1 Enable Rapid and Seamless Upstream Process Development and Scale-Up for CHO-K1 Cells
Efficient-Pro Medium and Feed 1 Enable Rapid and Seamless Upstream Process Development and Scale-Up for CHO-K1 Cells

Nov 21, 2024

Emerson white paper
Sponsored Content
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency

Nov 12, 2024